相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CART cells and clearance of bulky lymphoma
Paul-Joseph Aspuria et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Effects of interleukin-2 in immunostimulation and immunosuppression
Jonathan G. Pol et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma
Paolo Strati et al.
BLOOD ADVANCES (2020)
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Alexandre V. Hirayama et al.
BLOOD (2019)
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
Adam D. Cohen et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
Frederick L. Locke et al.
LANCET ONCOLOGY (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
Jonathan T. Sockolosky et al.
SCIENCE (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
Noelle Frey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
James N. Kochenderfer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
interleukin-2: Biology, Design and Application
Natalia Arenas-Ramirez et al.
TRENDS IN IMMUNOLOGY (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors
Enxiu Wang et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
Shannon L. Maude et al.
CANCER JOURNAL (2014)
The IL-2 cytokine family in cancer immunotherapy
Geok Choo Sim et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Michal J. Besser et al.
CLINICAL CANCER RESEARCH (2013)
Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
Christopher A. Klebanoff et al.
CLINICAL CANCER RESEARCH (2011)
IL-7 determines the homeostatic fitness of T cells by distinct mechanisms at different signalling thresholds in vivo
Claire Pearson et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells
David M. Barrett et al.
HUMAN GENE THERAPY (2011)
Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells
Matthew E. Pipkin et al.
IMMUNITY (2010)
Phosphoinositide (3,4,5)-Triphosphate Binding to Phosphoinositide-Dependent Kinase 1 Regulates a Protein Kinase B/Akt Signaling Threshold That Dictates T-Cell Migration, Not Proliferation
Caryll Waugh et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
Michael C. Milone et al.
MOLECULAR THERAPY (2009)
Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28
Vincenzo Mirenda et al.
BLOOD (2007)
Increased intensity lymphodepletion and adoptive immunotherapy - how far can we go?
Pawel Muranski et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Isolating and engineering human antibodies using yeast surface display
Ginger Chao et al.
NATURE PROTOCOLS (2006)
Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool
F Melchionda et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy
CA Klebanoff et al.
TRENDS IN IMMUNOLOGY (2005)
Revised guides for organ sampling and trimming in rats and mice - Part 3 - A joint publication of the RITA and NACAD groups
G Morawietz et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2004)
Revised guides for organ sampling and trimming in rats and mice - Part 2 - A joint publication of the RITA and NACAD groups
B Kittel et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2004)
Revised guides for organ sampling and trimming in rats and mice - Part 1 - A joint publication of the RITA and NACAD groups
C Ruehl-Fehlert et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2003)
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
JN Blattman et al.
NATURE MEDICINE (2003)
分享论文
